OTC · MICR
Micron Solutions, Inc.
$0.05$0.00 (0.0%)
Micron Solutions, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.2% below the high.
Loading market information…
OTC · ARTH · USD
Stock price, earnings
Quote as of May 2, 2025, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Arch Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.99% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Arch Therapeutics, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Arch Therapeutics, Inc., operating alongside its affiliated companies, functions as a biotechnology firm within the United States. The organization focuses on developing and commercializing products derived from its unique AC5 self-assembling technology platform. These innovations are engineered to arrest bleeding, control fluid leakage, and assist in wound care during surgical interventions, following trauma, throughout interventional medical procedures, or in cases of disease. Its leading products, the AC5 advanced wound system and the AC5 topical hemostat, are specifically designed for application on the skin, proving effective for managing intricate chronic wounds or acute surgical injuries. The company was established in 2006 and is headquartered in Framingham, Massachusetts.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:06 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2023 | Feb 14, 2023 | -$1.44-172.0% vs estimate | $6.26K-99.83% vs estimate |
|---|
| Q4 2022 | Dec 28, 2022 | -$2.000.0% vs estimate | $1.57K |
|---|
THE ANALYST VIEW
3 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.05$0.00 (0.0%)
Micron Solutions, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.2% below the high.
$0.00$0.00 (0.0%)
IMV Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00+$0.00 (+900.0%)
Beleave Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
$0.00-$0.00 (0.0%)
Molecular Templates, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.99% below the high.
$0.00-$0.00 (-100.0%)
MDEChem, Inc.: Healthcare · Biotechnology.
$0.00$0.00 (0.0%)
Discover Wellness Solutions Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
Orchid Ventures, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00-$0.00 (-100.0%)
ACI Global Corporation: Healthcare · Medical - Pharmaceuticals.
